Previous close | 4.3000 |
Open | 4.3000 |
Bid | 0.6000 |
Ask | 4.9000 |
Strike | 60.00 |
Expiry date | 2024-12-20 |
Day's range | 4.3000 - 4.3000 |
Contract range | N/A |
Volume | |
Open interest | 17 |
SOMERSET, N.J., May 29, 2024--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, NY on Thursday, June 6, 2024, at 10:30 a.m. ET.
SOMERSET, N.J., May 23, 2024--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new and updated data from the CARTITUDE clinical development program evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for patients with multiple myeloma will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2024 European Hematology Association’s (EHA) Hybrid Congress.
Discover how Legend Biotech's robust Q1 performance and strategic initiatives are setting the stage for sustained growth.